Catalyst
Slingshot members are tracking this event:
Arrowhead Pharma (ARWR) Likely to Announce New Data from Ongoing Phase 2 Studies of ARC-520 in Hepatitis-B in 2016
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| ARWR |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Apr 13, 2016
Occurred Source:
http://www.businesswire.com/news/home/20160413005533/en/Arrowhead-Pharmaceuticals-Presents-Promising-ARC-520-Hepatitis-Data
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Phase 2 Data, Arc-520, Hepatitis-b, 2016
